Tag: Purastat

In numerous clinical studies involving hundreds of patients, no serious adverse events have been directly attributed to the use of PuraStat itself [1.3.7, 1.7.5, 1.7.6]. This article details the known safety profile and answers the question: what are the side effects of PuraStat?

Gastrointestinal (GI) bleeding accounts for over 1.5 million healthcare visits in the United States annually [1.8.3]. When managing this condition, endoscopists may ask, is PuraStat a hemospray? The answer is no; they are distinct hemostatic agents with different compositions and mechanisms [1.2.5].

According to clinical studies, the use of PuraStat® has shown high rates of initial hemostatic success in endoscopic procedures for GI bleeding. For healthcare professionals, understanding **how to use Purestat** (PuraStat®) effectively is crucial for managing bleeding and ensuring patient safety during and after endoscopic interventions.

Clinical studies have shown PuraStat achieves high rates of initial hemostasis, particularly for mild and moderate bleeding during endoscopic procedures. So, **what is PuraStat used for**? It is a versatile peptide gel primarily employed to stop bleeding in various surgical and gastrointestinal settings.